相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101
Qingfeng Yu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction Is Sufficient to Replace α1-Adrenergic Tension in the Human Prostate
Martin Hennenberg et al.
PROSTATE (2017)
Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer
Riley A. Hampsch et al.
ONCOTARGET (2017)
Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2
Yiming Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate
Yiming Wang et al.
PLOS ONE (2016)
Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864
Y. Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study
Luca Cindolo et al.
EUROPEAN UROLOGY (2015)
Critical off-target effects of the widely used Rac1 inhibitors NSC23766 and EHT1864 in mouse platelets
S. Duetting et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Rate and associated factors of solifenacin add-on after tamsulosin monotherapy in men with voiding and storage lower urinary tract symptoms
H. N. Lee et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2015)
Local Mineralocorticoid Receptor Activation and the Role of Rac1 in Obesity-Related Diabetic Kidney Disease
Shigetaka Yoshida et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2014)
Prostatic α1-Adrenoceptors: New Concepts of Function, Regulation, and Intracellular Signaling
Martin Hennenberg et al.
NEUROUROLOGY AND URODYNAMICS (2014)
Comparative Effectiveness of Oral Drug Therapies for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Systematic Review and Network Meta-Analysis
Xinghuan Wang et al.
PLOS ONE (2014)
PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence
Akiko Hayashi-Takagi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate
Thomas Kunit et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms
Claudius Fuellhase et al.
EUROPEAN UROLOGY (2013)
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
Matthias Oelke et al.
EUROPEAN UROLOGY (2013)
Efficacy of Silodosin for Relieving Benign Prostatic Obstruction: Prospective Pressure Flow Study
Yoshihisa Matsukawa et al.
JOURNAL OF UROLOGY (2013)
OPINION The link between benign prostatic hyperplasia and prostate cancer
David D. Orsted et al.
NATURE REVIEWS UROLOGY (2013)
Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486
Bridget M. Dolan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle
Martin Hennenberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
NSC23766, a Widely Used Inhibitor of Rac1 Activation, Additionally Acts as a Competitive Antagonist at Muscarinic Acetylcholine Receptors
Magdolna Levay et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Angiotensin II- and Salt-Induced Kidney Injury through Rac1-Mediated Mineralocorticoid Receptor Activation
Wakako Kawarazaki et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction
Debra E. Irwin et al.
BJU INTERNATIONAL (2011)
Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH)
S. Ventura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms
Frank Strittmatter et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe
Christopher R. Chapple et al.
EUROPEAN UROLOGY (2011)
Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review
Antonio Alcaraz et al.
EUROPEAN UROLOGY (2009)
An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently
Julien Viaud et al.
MOLECULAR CANCER THERAPEUTICS (2009)
An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase
Sean W. Deacon et al.
CHEMISTRY & BIOLOGY (2008)
Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of rac family small GTPases
Adam Shutes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The long-term outcome of medical therapy for BPH
Stephan Madersbacher et al.
EUROPEAN UROLOGY (2007)
RAC1 inhibition targets amyloid precursor protein processing by γ-secretase and decreases Aβ production in vitro and in vivo
L Désiré et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of Src tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice
MV Yezhelyev et al.
CLINICAL CANCER RESEARCH (2004)
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Y Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Urodynamic effects of alpha-adrenoceptor blockers: A review of clinical trials
BBM Kortmann et al.
UROLOGY (2003)
The specificities of protein kinase inhibitors: an update
J Bain et al.
BIOCHEMICAL JOURNAL (2003)
分享论文
